We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Monoclonal Antibodies to the Dengue Virus NS1
Product News

New Monoclonal Antibodies to the Dengue Virus NS1

New Monoclonal Antibodies to the Dengue Virus NS1
Product News

New Monoclonal Antibodies to the Dengue Virus NS1


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "New Monoclonal Antibodies to the Dengue Virus NS1"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Dengue Virus is endemic in tropical countries world wide. It causes an insect-borne (mosquitoes) infection that manifests as Dengue Fever.

However the infection can progress to more serious conditions including hemorrhagic fever. There are 4 serotypes of the virus and all are capable of causing disease.

A non-structural glycoprotein (NS1) is produced during acute infection and can be found at high levels in patient serum.

ViroStat has released several new monoclonal antibodies to the NS1 of Dengue virus.

These antibodies recognize the NS1 protein of all 4 Dengue serotypes and are powerful tools for researchers and developers of rapid detection methods.

Advertisement